Neoplasms, Cystic, Mucinous, and Serous
"Neoplasms, Cystic, Mucinous, and Serous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms containing cyst-like formations or producing mucin or serum.
| Descriptor ID |
D018297
|
| MeSH Number(s) |
C04.557.470.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Cystic, Mucinous, and Serous".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Cystic, Mucinous, and Serous".
This graph shows the total number of publications written about "Neoplasms, Cystic, Mucinous, and Serous" by people in this website by year, and whether "Neoplasms, Cystic, Mucinous, and Serous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Cystic, Mucinous, and Serous" by people in Profiles.
-
Chiang AL, Lee LS. Clinical approach to incidental pancreatic cysts. World J Gastroenterol. 2016 Jan 21; 22(3):1236-45.
-
Hong SK, Loren DE, Rogart JN, Siddiqui AA, Sendecki JA, Bibbo M, Coben RM, Meckes DP, Kowalski TE. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts. Gastrointest Endosc. 2012 Apr; 75(4):775-82.
-
Rosenberger LH, Stein LH, Witkiewicz AK, Kennedy EP, Yeo CJ. Intraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literature. J Gastrointest Surg. 2012 Apr; 16(4):762-70.
-
Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res. 2006 Sep 1; 66(17):8404-12.